Found 10 results
Name | Type of Offering | Accepted Date |
---|---|---|
PanTher Therapeutics, Inc.
|
D | 2016-11-10 09:18:38 |
Amount To Be Raised
$500,000
Associated Brokers / Dealers
N/A
CIK Number
0001644045
Filed Document
0001644045-16-000006
Exclusions or Exemptions
506b
Accepted Date
2016-11-10 09:18:38
Type of Offering
D
Industry
Other Health Care
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PanTher Therapeutics, Inc.
|
D | 2025-04-03 12:40:11 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001644045
Filed Document
0001644045-25-000003
Exclusions or Exemptions
506b
Accepted Date
2025-04-03 12:40:11
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
PanTher Therapeutics, Inc.
|
D | 2020-05-14 15:01:04 |
Amount To Be Raised
$268,061
Associated Brokers / Dealers
N/A
CIK Number
0001644045
Filed Document
0001644045-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-05-14 15:01:04
Type of Offering
D
Industry
Other Health Care
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PanTher Therapeutics, Inc.
|
D | 2022-06-23 17:31:21 |
Amount To Be Raised
$1,200,000
Associated Brokers / Dealers
N/A
CIK Number
0001644045
Filed Document
0001644045-22-000002
Exclusions or Exemptions
506b
Accepted Date
2022-06-23 17:31:21
Type of Offering
D
Industry
Other Health Care
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PanTher Therapeutics, Inc.
|
D | 2020-05-18 08:52:09 |
Amount To Be Raised
$209,488
Associated Brokers / Dealers
N/A
CIK Number
0001644045
Filed Document
0001644045-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-05-18 08:52:09
Type of Offering
D
Industry
Other Health Care
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PanTher Therapeutics, Inc.
|
D | 2022-12-19 10:40:28 |
Amount To Be Raised
$2,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001644045
Filed Document
0001644045-22-000003
Exclusions or Exemptions
506b
Accepted Date
2022-12-19 10:40:28
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PanTher Therapeutics, Inc.
|
D | 2023-12-15 17:35:43 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001644045
Filed Document
0001644045-23-000001
Exclusions or Exemptions
506b
Accepted Date
2023-12-15 17:35:43
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PanTher Therapeutics, LLC
|
D | 2015-06-08 |
Amount To Be Raised
$500,000
Associated Brokers / Dealers
N/A
CIK Number
0001644045
Filed Document
0001644045-15-000001
Exclusions or Exemptions
506b
Accepted Date
2015-06-08
Type of Offering
D
Industry
Other Health Care
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PanTher Therapeutics, Inc.
|
D | 2020-06-04 14:18:53 |
Amount To Be Raised
$7,027,513
Associated Brokers / Dealers
N/A
CIK Number
0001644045
Filed Document
0001644045-20-000003
Exclusions or Exemptions
506b
Accepted Date
2020-06-04 14:18:53
Type of Offering
D
Industry
Other Health Care
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
PanTher Therapeutics, Inc.
|
D/A | 2021-06-02 11:05:50 |
Amount To Be Raised
$7,334,474
Associated Brokers / Dealers
N/A
CIK Number
0001644045
Filed Document
0001644045-21-000001
Exclusions or Exemptions
506b
Accepted Date
2021-06-02 11:05:50
Type of Offering
D/A
Industry
Other Health Care
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|